Brief: Alimera Sciences, Inc. reports Q3 EPS USD -0.06
26/10/2023 14:35
Oct 26 (Reuters) - Alimera Sciences, Inc. Q3 income from operations USD 1.854 million. * Q3 operating expenses USD 18.752 million * Q3 net revenue USD 23.364 million * Q3 gross profit USD 20.606 million * Q3 EPS USD -0.06 * Q3 net income USD -1.354 million
Recent news on Alimera Sciences
See all newsBrief: ANI Pharmaceuticals And Alimera Sciences Announce Closing Date Of Merger
Brief: Ani Pharmaceuticals Provides Update On Closing Of Acquisition Of Alimera Sciences
U.S. STOCKS ON THE MOVE-JPMorgan, automakers, energy firms
U.S. STOCKS ON THE MOVE-Arrowhead Pharma, Boeing, Centessa Pharma
Brief: Alimera Sciences Files Lawsuit To Compel ANI To Close Merger